<DOC>
	<DOC>NCT01254383</DOC>
	<brief_summary>This study will evaluate if an orally disintegrating tablet of sildenafil will have similar pharmacokinetic properties as the conventional tablet of sildenafil.</brief_summary>
	<brief_title>Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Versus To ViagraÂ® Oral Tablet.</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Otherwise healthy male subjects age 45 years or older with or without erectile dysfunction. Body Mass Index (BMI) of 17.5 to 32.5 kg/m2. Signed and dated informed consent document. Evidence or history of clinically significant abnormalities Have baseline orthostatic hypotension Positive drug screen, excessive alcohol and tobacco use</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Bioequivalence Oral Dissolving Tablet</keyword>
</DOC>